Skip to main content

Table 1 Schedule of enrolment, variables and measures

From: Personalised informed choice on evidence and controversy on mammography screening: study protocol for a randomized controlled trial

Timepoint

 

Trial period

Enrollment

Allocation

Post-allocation

Baseline

0

Post (7–10 days after randomization)

Registration and signed informed consent

X

  

Allocation

 

X

 

Demographics

X

  

Use of internet

X

  

Experience with other screenings

X

  

Previous mammography

X

  

Previous participation in screening programmes

X

  

Family history of breast cancer

X

  

Perceived risk of breast cancer

X

  

Knowledge of breast cancer screening

X

 

X

Attitude to breast cancer screening

X

 

X

Intention regarding breast cancer screening

X

 

X

Satisfaction and acceptability of the information received

  

X

Decisional conflict

  

X